1h Free Analyst Time
The cell therapy market is forecasted to grow by USD 84.58 billion during 2023-2028, accelerating at a CAGR of 73.89% during the forecast period. The report on the cell therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by limitations in traditional organ transplantations fueling demand for cell therapies, increasing funding in cell-based research, and proven effectiveness of car t-cell therapy.
The cell therapy market is segmented as below:
By Type
- Autologous
- Allogenic
By Application
- Malignancies
- Musculoskeletal
- Cardiovascular
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the cell therapy market covers the following areas:
- Cell therapy market sizing
- Cell therapy market forecast
- Cell therapy market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global cell therapy market: Astellas Pharma Inc., Athersys Inc., Avita Medical Inc., BioCardia Inc., BioSenic SA, Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co., Capricor Therapeutics Inc., Castle Creek Biosciences Inc., CellSeed Inc., Cellular Biomedicine Group Inc., Celyad Oncology SA, Gilead Sciences Inc., Lineage Cell Therapeutics Inc., Lisata Therapeutics Inc., Mesoblast Ltd., Novartis AG, Pharmicell Co. Ltd., Sanpower Group Co. Ltd., and ThermoGenesis Holdings Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing focus on cell therapy products."
According to the report, one of the major drivers for this market is the limitations in traditional organ transplantations fueling demand for cell therapies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Astellas Pharma Inc.
- Athersys Inc.
- Avita Medical Inc.
- BioCardia Inc.
- BioSenic SA
- Brainstorm Cell Therapeutics Inc.
- Bristol Myers Squibb Co.
- Capricor Therapeutics Inc.
- Castle Creek Biosciences Inc.
- CellSeed Inc.
- Cellular Biomedicine Group Inc.
- Celyad Oncology SA
- Gilead Sciences Inc.
- Lineage Cell Therapeutics Inc.
- Lisata Therapeutics Inc.
- Mesoblast Ltd.
- Novartis AG
- Pharmicell Co. Ltd.
- Sanpower Group Co. Ltd.
- ThermoGenesis Holdings Inc.
